Abderrahim Nemmar Selected Research

Anaphylaxis (Anaphylactic Shock)

10/2022	Combined Treatment with KV Channel Inhibitor 4-Aminopyridine and either γ-Cystathionine Lyase Inhibitor β-Cyanoalanine or Epinephrine Restores Blood Pressure, and Improves Survival in the Wistar Rat Model of Anaphylactic Shock.
11/2016	4-Aminopyridine, A Blocker of Voltage-Dependent K+ Channels, Restores Blood Pressure and Improves Survival in the Wistar Rat Model of Anaphylactic Shock.
11/2013	Glyburide, a K(+)(ATP)channel blocker, improves hypotension and survival in anaphylactic shock induced in Wistar rats sensitized to ovalbumin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Abderrahim Nemmar Research Topics

Disease

47	Inflammation (Inflammations) 01/2024 - 04/2004
17	Thrombosis (Thrombus) 01/2022 - 10/2002
16	Chronic Renal Insufficiency 01/2024 - 01/2014
15	Pneumonia (Pneumonitis) 01/2022 - 03/2003
11	Necrosis 01/2021 - 01/2010
10	Fibrosis (Cirrhosis) 01/2024 - 01/2017
10	Body Weight (Weight, Body) 01/2021 - 10/2002
7	Acute Kidney Injury (Acute Renal Failure) 04/2022 - 01/2010
7	Chronic Kidney Failure (Chronic Renal Failure) 01/2016 - 03/2010
6	Hypertension (High Blood Pressure) 02/2023 - 02/2008
6	Neoplasms (Cancer) 11/2022 - 10/2011
3	Neoplasm Metastasis (Metastasis) 11/2022 - 11/2019
3	Anaphylaxis (Anaphylactic Shock) 10/2022 - 11/2013
3	Kidney Diseases (Kidney Disease) 02/2019 - 03/2014
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2014 - 02/2013
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2024 - 02/2023
2	Hypoxia (Hypoxemia) 09/2023 - 02/2017
2	Cardiotoxicity 05/2023 - 01/2019
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2022 - 11/2021
2	Cardiovascular Diseases (Cardiovascular Disease) 04/2022 - 02/2012
2	Thrombophilia 02/2022 - 01/2017
2	Lung Neoplasms (Lung Cancer) 11/2021 - 03/2007
2	Proteinuria 01/2020 - 01/2017
2	Pain (Aches) 11/2019 - 02/2008
2	Pancreatic Neoplasms (Pancreatic Cancer) 11/2019 - 10/2011
2	Lung Injury 01/2019 - 02/2018
2	Erectile Dysfunction 12/2018 - 10/2011
2	Hemolysis 01/2018 - 01/2012
2	Hypotension (Low Blood Pressure) 11/2016 - 11/2013
2	Leukocytosis (Pleocytosis) 01/2016 - 04/2013
2	Chronic Obstructive Pulmonary Disease (COPD) 12/2012 - 03/2007
1	Gliosis 04/2023
1	Neuroinflammatory Diseases 04/2023

Drug/Important Bio-Agent (IBA)

22	Adenine FDA LinkGeneric 01/2024 - 03/2010
20	Vehicle Emissions (Emissions, Vehicle)IBA 01/2022 - 03/2003
20	1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA 02/2018 - 12/2003
14	SmokeIBA 01/2024 - 12/2012
11	Gum Arabic (Acacia, Gum)FDA Link 01/2020 - 03/2010
7	Cisplatin (Platino)FDA LinkGeneric 04/2022 - 12/2013
7	Interleukin-6 (Interleukin 6)IBA 01/2021 - 12/2011
6	AntioxidantsIBA 01/2024 - 11/2013
6	EnzymesIBA 01/2024 - 11/2013
6	Proteins (Proteins, Gene)FDA Link 04/2022 - 01/2003
5	Particulate MatterIBA 01/2022 - 10/2002
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 01/2018
5	CreatinineIBA 01/2021 - 01/2017
4	InterleukinsIBA 01/2022 - 01/2015
4	Streptozocin (Streptozotocin)FDA Link 01/2021 - 04/2013
4	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2018
4	Glutathione (Reduced Glutathione)IBA 01/2019 - 11/2013
4	Lipocalin-2IBA 01/2019 - 01/2017
4	Histamine (Histamine Dihydrochloride)FDA Link 09/2004 - 01/2003
3	Superoxide DismutaseIBA 01/2022 - 01/2015
3	nootkatoneIBA 01/2019 - 01/2018
3	Cystatin CIBA 01/2019 - 01/2018
3	ceric oxide (cerium dioxide)IBA 01/2019 - 01/2017
3	8-epi-prostaglandin F2alphaIBA 01/2019 - 04/2013
3	AlbuminsIBA 12/2018 - 01/2018
3	Urea (Carbamide)FDA LinkGeneric 12/2018 - 01/2017
3	Silicon Dioxide (Silica)FDA LinkGeneric 01/2016 - 04/2005
3	Free RadicalsIBA 01/2013 - 04/2004
3	Polystyrenes (Polystyrene)IBA 09/2004 - 10/2002
2	Caspase 3 (Caspase-3)IBA 09/2023 - 01/2021
2	SilverIBA 05/2023 - 10/2016
2	catalpolIBA 01/2023 - 01/2022
2	4-Aminopyridine (4 Aminopyridine)FDA Link 10/2022 - 11/2016
2	Glucose (Dextrose)FDA LinkGeneric 04/2022 - 01/2019
2	ImmunosorbentsIBA 01/2022 - 01/2021
2	Citric Acid (Citrate)FDA LinkGeneric 01/2019 - 01/2018
2	CanagliflozinIBA 01/2019 - 01/2019
2	CatalaseIBA 01/2019 - 01/2018
2	Glutathione Reductase (Glutathione-Disulfide Reductase)IBA 01/2019 - 01/2015
2	Povidone (Crospovidone)IBA 01/2019 - 01/2018
2	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2019 - 01/2019
2	Sildenafil Citrate (Viagra)FDA Link 12/2018 - 10/2011
2	Hexosaminidases (Hexosaminidase)IBA 12/2018 - 10/2011
2	AdiponectinIBA 01/2018 - 01/2018
2	CurcuminIBA 01/2018 - 01/2017
2	Betaine (C.B.B.)FDA Link 01/2017 - 07/2015
2	OvalbuminIBA 11/2016 - 11/2013
2	chrysinIBA 01/2016 - 01/2015
2	Emodin (Archin)IBA 08/2015 - 01/2015
2	C-Reactive ProteinIBA 04/2013 - 01/2012
2	titanium dioxide (Titania)FDA Link 01/2011 - 05/2008
2	AminesIBA 01/2003 - 10/2002
1	Atrial Natriuretic Factor (ANF)IBA 01/2024
1	Cytochromes c (Cytochrome c)IBA 09/2023
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 05/2023
1	Volatile Oils (Essential Oils)IBA 11/2022
1	LyasesIBA 10/2022
1	CystathionineIBA 10/2022
1	Epinephrine (Adrenaline)FDA LinkGeneric 10/2022
1	CholesterolIBA 04/2022
1	bisabolol (levomenol)IBA 04/2022
1	Plasminogen Activators (Plasminogen Activator)IBA 02/2022
1	Thromboplastin (Tissue Factor)IBA 02/2022
1	Fibrinogen (Factor I)FDA Link 02/2022
1	Adenosine Diphosphate (ADP)IBA 01/2022
1	Pancreatic Elastase (Elastase)IBA 01/2022

Therapy/Procedure

3	Therapeutics 11/2022 - 11/2019